+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07225205

Randomized Trial of Home Intravenous Fluid Therapy After Radical Cystectomy for Bladder Cancer to Reduce Hospital Readmissions

Led by Johns Hopkins University · Updated on 2025-11-20

130

Participants Needed

2

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying patients with muscle-invasive bladder cancer who are undergoing radical cystectomy, a major surgery often linked to high rates of complications and hospital readmissions. This trial evaluates whether adding a home intravenous fluid IVF infusion program to an Enhanced Recovery After Surgery ERAS protocol can reduce 90-day hospital readmissions compared to ERAS alone. The study is a randomized controlled trial at a single institution aiming to provide clearer evidence on the benefits and risks of home IVF after surgery. Participants are randomly assigned to one of two groups one group receives the ERAS protocol plus a home IVF program with 1 liter of fluid lactated ringers or normal saline given three times a week for four weeks via vascular access established before or after surgery the other group receives the ERAS protocol alone without home IVF. Patients in the home IVF group may have vascular access from prior chemotherapy or receive a midline catheter placed post-operatively. Both groups receive home nursing care for wound and ostomy management and education. During the study, patients will have routine follow-up including phone calls at 30 and 90 days after surgery to assess complications, emergency visits, and hospital readmissions. Clinic visits for ostomy teaching and wound checks occur about 7 to 14 days after surgery. Researchers will measure the percentage of participants with hospital readmissions within 90 days as the primary outcome, along with secondary outcomes like 30-day readmissions, emergency department visits, and all-cause complications. The total study duration for each participant includes the four-week home care period and follow-up assessments.

CONDITIONS

Brief Title

Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy

Research Team

T

Tyler S Garman, MD

M

Max R Kates, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here